Royalty Pharma RPRX Total investments
Total investments at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFVNINoncurrent.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's total investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's total investments?
- Royalty Pharma (RPRX) reported total investments of $173.27M in Q1 2026.
- How has Royalty Pharma's total investments changed year-over-year?
- Royalty Pharma's total investments increased by 22.8% year-over-year, from $141.08M to $173.27M.
- What is the long-term trend for Royalty Pharma's total investments?
- Over 5 years (2020 to 2025), Royalty Pharma's total investments has grown at a -10.5% compound annual growth rate (CAGR), from $298.69M to $171.31M.
- What does total investments mean?
- This represents the total value of all investment holdings, including debt securities, equity stakes, and other financial instruments held for long-term appreciation or strategic purposes. It reflects the company's capital allocation strategy beyond its core royalty portfolio.